Back
Caribou Biosciences, Inc. 10K Form
Sell
42
CRBU
Caribou Biosciences, Inc.
Last Price:
$1.90
Seasonality Move:
-18.24%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CRBU News And Ratings
See the #1 stock for the next 7 days that we like better than CRBU
CRBU Financial Statistics
Sales & Book Value
| Annual Sales: | $10M |
|---|---|
| Cash Flow: | $-25.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.52 |
| Price / Book: | 1.25 |
Profitability
| EPS (TTM): | -1.69760 |
|---|---|
| Net Income (TTM): | $-157.1M |
| Gross Margin: | $6.1M |
| Return on Equity: | -74.16% |
| Return on Assets: | -57.99% |
Caribou Biosciences, Inc. Earnings Forecast
Key Caribou Biosciences, Inc. Financial Ratios
-
The Gross Profit Margin over the past 6 years for CRBU is 60.71%.
-
The Selling, General & Administrative Expenses for CRBU have been equal to 464.85% of Gross Profit Margin.
-
The Research & Development expenses have been 1,302.31% of Revenue.
-
The Net Earning history of CRBU is -1,491.95% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 1 years.
Caribou Biosciences, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CRBU |
| Website: | cariboubio.com |
Debt
| Debt-to-Equity Ratio: | 0.18 |
|---|---|
| Current Ratio: | 5.54 |
| Quick Ratio: | 5.29 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CRBU Technical Analysis vs Fundamental Analysis
Sell
42
Caribou Biosciences, Inc. (CRBU)
is a Sell
Is Caribou Biosciences, Inc. a Buy or a Sell?
-
Caribou Biosciences, Inc. stock is rated a SellThe current Caribou Biosciences, Inc. [CRBU] share price is $1.89. The Score for CRBU is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.